All Type of News
Cyramza Inj registered health insurance benefits with application of RSA from 1 May
Cyramza, a stomach cancer therapy, will be registered in the list of health insurance benefits from the 1st of May after drug price negotiations and decisions at the committee.
The Ministry of Health and Welfare(MOHW...
KPDA, “31 pharmas have accepted credit card payments for drugs”
There were reportedly 31 pharmaceutical companies which accepted credit card payments for medicinal drugs. Particularly, 10 pharmaceutical companies including Dong-A ST was reportedly positive with credit card payment...
42 generic drugs referencing Bukwang Pharm’s ‘Dexid Tab’ were bioequivalently tested this year
This year, 291 pharmaceutical products have been bioequivalently tested. The number was reportedly increased by 46% compared to the same time period.
This means Korean pharmaceutical companies have been very active i...
Eye drop manufacturers strongly opposing to disposable eye drop price cuts
In regards to the drug reassessment standards which will become a base to cut drug price for disposable eye drops, eye drop manufacturers have strongly opposed to the government and argues that the drug price will dro...
“While this year’s drug price negotiations will be prepared like last year, we will consider Moon Jae-In Care”
The National Health Insurance Service(NHIS) announced to carry out upcoming drug price negotiations just like last year, but also to conduct them carefully in consideration of the Moon Jae-In Care in various direction...
Hanmi Pharm’s innovative anticancer drug ‘Posiotinib’ published in international SCI journal
A research result of Poziotinib, a targeted therapy for cancer developed by Hanmi Pharm, was registered in the online version of Nature Medicine, an international SCI(Science Citation Index) journal.
Spectrum Pharmac...
“It is urgent to develop new drugs to address antibiotic resistance threatening humanity”
As the antibiotic resistance issue is getting serious, the world is struggling to find a solution. Even in Korea, some organizations have started to make moves to participated in finding the solution.
When it comes t...
Prostatic cancer treatments ‘Jevtana’ and ‘Zytiga’ newly registered in list of health insurance benefits this May
104 products, such as Jevtana and Zytiga, prostate cancer therapies, will be newly registered in the list of health insurance benefits this May.
The Ministry of Health and Welfare(MOHW) revised and placed the ‘Drug I...
Chair Jung-Hee Lee, “It is unreasonable for distribution association to request credit card payments”
Jung-Hee Lee, Chair of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association, expressed a stance that it is unfair for the Korea Pharmaceutical Distribution Association(KPDA) to ask pharmaceutical companie...
3 of 10 Korean pharmaceutical companies having debt ratio higher than 100%
3 of 10 Korean pharmaceutical companies were pointed out as a company with unsound financial structure with a debt ratio higher 100%.
Yakup Shinmoon(www.yakup.com) analyzed the debt ratio in 2017 audit reported that ...
